Professional Documents
Culture Documents
Transcathether renal denervation for the treatment of resistant hypertension: The first IJN experience
Setting up resistant hypertension clinic IJN (Malaysian National Heart Institute) is the first centre in Asia to perform the renal denervation on the 11th September 2010. Performed using the Symplicity Cathether system (Ardian Medtronic) Presence of a proctor- Dr. Justin Davies (Interventional cardiologist and Walport clinical lecturer at Imperial College, London)
Methods
Patients referred to IJN resistant hypertension clinic Stratified based on inclusion and exclusion criteria Medication compliance assessment Ambulatory blood pressure monitoring/investigations Screening for secondary hypertension Consented for renal denervation therapy Follow up
Inclusion criterias
Based on the SYMPLICITY-HTN 2 trial Systolic BP of more than 160 mmHg based on average 3 office BP reading previously measured (more than 150 mmHg for type 2 DM) Patient is adhering to a stable 3 or more antihypertensive medications Patient is 18-85 years of age
Exclusion criterias
Renal artery abnormalities ( Renal artery stenosis, diameter less than 4mm or 20mm in length) EGFR of less than (45ml/min/1.73m2) based on MDRD calculation criteria Type 1 diabetes mellitus Recent MI, Unstable angina and CVA within the last 6 months or scheduled or planned surgery in the next 6 months Haemodynamically significant valvular heart disease Pregnant, nursing or planning to be pregnant
Patient group
43 patients referred to the IJN resistant hypertension clinic
(N=4) excluded due to not meeting initial inclusion criteria (N=25) Resistant Hypertension (N=14) White coat hypertension
Antihypertensive medications
Average baseline office BP based on 3 previous outpatient clinic visits prior to referral
Results
Blood pressure changes from baseline and at follow up (2 weeks, 1 month, 3 month, 6 month and 12 month) Acute procedural safety and chronic procedural safety EGFR and renal profile at 2 weeks, 1 month and 3 month follow up Fasting sugar and HBAIC at 6 month follow up Composite cardiovascular endpoints (MACE)
Procedural analysis
Right renal artery ablation Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 2 5 5 3 2 Left renal artery ablation 4 5 5 4 0 Immediate procedural complications no no no no BP dropped to systolic 60 requiring inotrope and iv fluid no no Back pain resolved after 2 weeks no
6 6 6 6
5 4 5 5
140/81
138/65
Pre RDN
Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 Patient 6 Patient 7 Patient 8 Patient 9 160 182 167 165 189 170 226 186 203
Follow up at 2 week
198 169 198 172 153 179 226 191 145
Follow up at 3 month
232
Patient 9
88
65
Result: Mean BP
Pre RDN Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 Patient 6 105 126 113 133 134 105 Follow up at 2 weeks Follow up at 1 month Follow up at 3 month 129 130 130 117 115 112 129 130 114 140 129 100 109 94 143 130 122
Patient 7
Patient 8 Patient 9
149
144 126
150
152 89 176
Conclusions
Percutaneous catheter-based theraputic renal denervation is safe and simple Symplicity 2 study has shown that there is BP lowering benefit with no significant decline in renal function Longer follow up is necessary to observe further response to BP stabilization in our small cohort